Andrew J. Stewart

Insider Reports History

Entity
Individual
Location
C/O Bausch + Lomb Corporation, 400 Somerset Corporate Blvd., Bridgewater, NJ
Signature
/s/ Debra E. Levin, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Stewart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bausch & Lomb Corp Officer Common Shares, No Par Value 46K $685K $14.90 Apr 24, 2024 Direct
Bausch & Lomb Corp Officer Non-Qualified Stock Options (right to purchase) 50.8K Feb 28, 2024 Direct

Insider Reports Filed by Andrew J. Stewart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLCO Bausch & Lomb Corp Apr 24, 2024 1 -$58.8K 4 Apr 26, 2024 Officer
BLCO Bausch & Lomb Corp Feb 28, 2024 2 $0 4 Mar 1, 2024 Officer
BLCO Bausch & Lomb Corp Apr 24, 2023 1 $0 4 Apr 26, 2023 The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals.
BLCO Bausch & Lomb Corp Apr 24, 2023 0 $0 3 Apr 26, 2023 Officer